HALO — Halozyme Therapeutics Inc. Stock Price, Chart & Financials

HALO

Halozyme Therapeutics Inc.Stock · Health Care

$100.67−$1.12 (-1.10%)as of market close, Aug 13, 2026

☾ After hours:$100.67+0.00%3:59 PM ET

CompareLLYUNHJNJABBVISRGTMO

What would $1,000 invested in HALO be worth today? →

HALO returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $100.64
Change YTD: +49.58%
Market cap: 11.4B
Enterprise value: 13.4B
Shares outstanding: 113.5M
52W low: $61.23
52W high: $104.78
From 52W high: -3.92%
From 52W low: +64.36%
52W range: 90%
Beta: 0.85

Volume

Rel volume: 0.05×
30D volume: 2.1M
30D $ vol: 183.6M

Fundamentals

Sales (ttm): 1.7B
Sales/share: $14.66
EPS (ttm): $3.39
FCF (ttm): 806.2M
FCF/share: $7.10
Book value/share: $1.26
Net margin: 24.86%
ROE: 288.13%
ROA: 16.05%
Debt / equity: 13.50×
Current ratio: 2.71

Growth (CAGR, ttm) · 10Y

Sales: +27.49%
Net income: n/a
FCF: n/a
Shares: -1.30%

Per-share growth (CAGR, ttm) · 10Y

EPS: n/a
Sales/share: +29.18%
FCF/share: n/a
Book value/share: +32.36%
Price: +25.66%
Total return: +25.66%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

: 29.7×
: 19.1×
Fwd P/E: 9.9×
: 6.9×
: 79.6×
: 14.2×
EV/EBITDA (fy): 22.0×
EV/Sales (ttm): 8.1×
: 7.06%
: 2.97%
: 2.97%
: 3.25%
: 3.25%

Vs own 10Y history

P/E: 67th
P/OI: 55th
P/S: 24th
P/B: 93rd
P/FCF: 25th

Bar = where today's multiple sits in HALO's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return#

-1.10%

+17.39%

+32.77%

+43.75%

YTD

+49.58%

+57.20%

+149.06%

Financial statements

Open full HALO financials →

Ticker	Theme	Price	1M	30D $Vol
NVS Novartis AG	Health Care	$152	+0.59%	268.9M
NVO Novo Nordisk A/S	Health Care	$46.73	-7.58%	555.7M
GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares)	Health Care	$50.46	-1.92%	212.8M
SNY Sanofi ADS	Health Care	$43.78	+0.23%	142.5M
TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	Health Care	$17.41	+5.84%	65M
ARGX argenx SE American Depositary Shares	Health Care	$857	-0.66%	251.9M
NTRA Natera Inc.	Health Care	$311	+12.05%	362.2M
RVMD Revolution Medicines Inc.	Health Care	$202	+9.48%	351.3M

Halozyme Therapeutics Inc. (HALO) trades at $100.67 with a live price and an interactive chart covering 22+ years of daily price history, plus key valuation metrics. ChartRow also publishes HALO's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full HALO financial statements →

HALO — Halozyme Therapeutics Inc. stock price, chart and key statistics